Companies: 10,795·Total market cap: $144.5T
SOPHiA GENETICS S.A.

SOPHiA GENETICS S.A.

SOPHNASDAQHealthcare● Active
$5.47
+$0.47(+9.40%)
Market Cap$392027789
P/E Ratio
52W High$5.7
52W Low$2.59
Overview

SOPHiA GENETICS S.A.(SOPH)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · SOPH · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.18soph eps ttm · soph earnings per shareEarnings history
PE Ratio (TTM)soph pe ratio ttm · soph price to earningsPE Ratio deep dive
Revenue (TTM)$81.2Msoph revenue ttm · soph annual revenueFull revenue history
Dividend Yield不分红does soph pay dividends · soph dividend yieldDividend history
Shares Outstanding67.5Msoph shares outstanding · soph floatShares outstanding history
Next EarningsAug 4, 2026Est.soph earnings date · soph next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$77.3M▲ +18.56% YoY
202320242025
sophia genetics s.a. revenue · soph revenue 2025
FY 2025Net Income-$79.0M▼ 26.41% YoY
202320242025
sophia genetics s.a. net income · soph profit 2025
FY 2025EPS$-1.17▼ 23.16% YoY
202320242025
soph eps · sophia genetics s.a. earnings per share 2025
TTM:Revenue: $81.2MNet Income: -$80.9MEPS: $-1.18View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy7 位分析师is soph a buy · soph analyst rating
Strong Buy
0
Buy
6
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$7.00Low
$5.47Current
$7.50Avg Target上涨空间 37.11%
$8.00High
soph price target · soph 12 month forecast

合计: 7 · 买入占比: 85.7%

根据过去 3 个月内 7 位华尔街分析师,SOPH 共识评级为 Buy,12 个月平均目标价 $7.50 (较现价 $5.47 上涨空间 37.11%)

股票表现

完整历史
1D+9.70%
1W+11.26%
1M+6.50%
3M+26.09%
YTD+17.45%
1Y+91.78%
5Y-67.27%

关于 SOPHiA GENETICS S.A.

CEOJurgi Camblong
IPO DateJul 23, 2021
Employees423
CountryCH

SOPHiA GENETICS S.A. SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from mul…

what is sophia genetics s.a. · soph stock overview · sophia genetics s.a. company profile · who is sophia genetics s.a. ceo · soph NASDAQ · sophia genetics s.a. headquarters · sophia genetics s.a. business segments

关于股票概览与关键数据

SOPHiA GENETICS S.A.(SOPH)是 Medical - Healthcare Information Services 行业的 Healthcare 类公司,于 Jul 23, 2021 在 NASDAQ 上市。截至最近交易日,SOPH 股价为 $5.47,市值约为 $392.0M。过去12个月累计回报 +91.78%,年初至今回报 +17.45%。

根据 7 位华尔街分析师,SOPHiA GENETICS S.A. 股票共识评级为Buy,12个月平均目标价为 $7.50。2025 财年 SOPHiA GENETICS S.A. 营收 $77.3M,净利润 -$79.0M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,SOPHiA GENETICS S.A.(SOPH)股价为 $5.47,在 NASDAQ 上市,52周区间为 $2.59 – $5.70。

SOPH 最新股价SOPH quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议